Asia petrochemical outlook H1 2019

January 2, 2019

The year 2019 promises many significant changes in Asia’s petrochemical markets amid booming production capacity and integration of petrochemical plants and refineries across China, and the global impact inflicted by the US-China trade war. This will be the year that opens the floodgates for massive new petrochemical capacities being brought on stream by private Chinese companies. They aim to integrate all the way upwards from their purified terephthalic acid and polyester plants to greenfield refineries.

Spotlight

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel antibiotics to treat the serious and life-threatening multidrug-resistant infections that pose a major and growing global health threat. Tetraphase’s proprietary breakthrough chemistry technology enables the design of molecules that can overcome antibiotic resistance. Our drug platform has led to the creation of more than 3,000 broad- and selective-spectrum antibiotic drug candidates. Tetraphase common stock trades under the NASDAQ symbol ‘TTPH.’ Tetraphase is well positioned to be a major player in the multidrug-resistant arena.

OTHER WHITEPAPERS
news image

Boost Your Business In Chemical Industry With Sap Commerce Cloud

whitePaper | April 21, 2023

A B2B E-Commerce platform also provides companies with access to real-time data and insights that can help to inform and guide their business decisions.

Read More
news image

The path to Net Zero for Eastern Europe

whitePaper | October 25, 2022

ICIS is the global source of Independent Commodity Intelligence Services. For 150 years, we have connected data, markets, and customers to create a comprehensive,

Read More
news image

Exploring quantum use cases for chemicals and petroleum

whitePaper | December 19, 2019

classically, the algorithms have exponential scaling. However, due to the nature of quantum algorithms, chemistry calculations have been predicted to scale polynomially, a promising step towards the ability to perform exact calculations on molecules that are currently out of reach.

Read More
news image

Characterizing adsorbents for gas separations

whitePaper | February 4, 2023

Hiden Isochema is a world leader in the design and manufacture of sorption instruments. We offer a range of fully automated gravimetric and manometric instruments for determining the equilibria and kinetics of gas and vapor sorption by liquids and materials.

Read More
news image

NASF SURFACE TECHNOLOGY WHITE PAPERS

whitePaper | July 1, 2022

It is widely recognized in many industries that sustainability is a key driver of innovation. Numerous companies, especially large ones who made sustainability as a goal, are achieving clearly more competitive advantages.

Read More
news image

plasticfree to future-proof plastics

whitePaper | January 20, 2023

Plastics are shrouded in controversial debates. While manufacturers have been highlighting the benefits of plastics for decades, there are more and more stakeholders demanding a complete refuse, referring to the environmental problems associated with the use of plastic.

Read More

Spotlight

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel antibiotics to treat the serious and life-threatening multidrug-resistant infections that pose a major and growing global health threat. Tetraphase’s proprietary breakthrough chemistry technology enables the design of molecules that can overcome antibiotic resistance. Our drug platform has led to the creation of more than 3,000 broad- and selective-spectrum antibiotic drug candidates. Tetraphase common stock trades under the NASDAQ symbol ‘TTPH.’ Tetraphase is well positioned to be a major player in the multidrug-resistant arena.

Events